Gi(l)Otrif®の投与量調整に関する実世界データ

基本情報

NCT ID

NCT02751879

ステータス

完了

試験のフェーズ

-

試験タイプ

観察

目標被験者数

228

治験依頼者名

Boehringer Ingelheim

概要

This is a non-interventional, multi-country, multi-site study based on existing data from medical records of patients treated with Gi(l)otrif® as part of the routine treatment according to the approved label. Data from real-world will help to understand if dose modifications are done similar as in LUX-Lung 3 trial and if the outcome on safety and effectiveness are as in trial settings. Furthermore, data on modified starting doses, the underlying reasons and effects on safety and outcome are needed.

対象疾患

依頼者（Sponsor）

実施施設 (2)